What has been done so far?

Over the last twenty years, the percentage of pregnant women who received at least three doses of IPTp, increased from 2% to just over 30%. In April 2015, RBM MiP WG launched a Global Call to Action to increase national coverage of IPTp. Following this call, many malaria endemic countries, donors, and organizations have taken steps to increase delivery of IPTp-SP. 

By 2016, 36 African countries had adopted WHO’s policy of providing at least three doses of IPTp to pregnant women. Three African manufacturers are also being supported to become WHO-prequalified producers of SP for IPTp. However, in 2020, only 32% of eligible pregnant women received the recommended three doses across sub-Saharan Africa.

Renewed Call of Action

Over 1000 people signed a letter under the umbrella of the RBM Partnership to End Malaria calling on decision makers to provide all eligible pregnant women with the malaria preventive treatment they need. This included more than 700 signatures from 43 countries and more than 300 organizations in Africa. A book with the signatures was handed over to the African Leaders Malaria Alliance at a media briefing and malaria awards’ ceremony at the 2023 African Union Summit.

Click here to Learn more about the campaign and watch MiP champion videos​